Colifoam (hydrocortisone acetate rectal foam): Supply issue resolved

Hydrocortisone acetate rectal foam (Colifoam) has been out of stock since early 2019. We are advised that resupply is expected by June 2023.

6 July 2023

Colifoam stock has arrived and has been released to wholesalers. 

New pharmacode listed 

The new registered product with a new pharmacode (2611120) and has been listed in the Schedule(external link).

Unfortunately this product has been delayed. 

The alternative, Cortifoam, remains the available product.

Alternative product: Cortifoam

Mylan have sourced a hydrocortisone product from the US, called Cortifoam (pharmacode 2608707).

This was listed in the Schedule from 1 June 2021.

Cortifoam is not Medsafe-approved. It must be prescribed and supplied under section 29 of the Medicines Act. 

Information for medical professionals about section 29 - Medsafe's website(external link)

Information for people taking unapproved medicines - Healthify website(external link)

About Cortifoam

Cortifoam in the Schedule(external link)

Hydrocortisone acetate in the NZ Formulary(external link)

Alternative agent

Clinect had previously sourced an alternative agent, prednisolone sodium – rectal foam 20 mg per dose (brand name: Essential Prednisolone). This was listed in the Pharmaceutical Schedule on 1 October 2020. 

Find the listing in the Pharmaceutical Schedule(external link)

Essential Prednisolone is not approved for use in New Zealand by Medsafe. It must be supplied under section 29 of the Medicines Act. We apologise for any inconvenience this causes. 

Who to contact

If you have questions about supply of Colifoam or Essential Prednisolone, contact your wholesaler or the product supplier.

You can call Clinect on 0800 138 803

If you have questions about funding, email